Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Savannah Tollefson"'
Autor:
Shawn R. Eagle, Ava M. Puccio, Denes V. Agoston, Ryan Soose, Michael Mancinelli, Rachel Nwafo, Peyton McIntyre, Allison Agnone, Savannah Tollefson, Michael Collins, Anthony P. Kontos, Walter Schneider, David O. Okonkwo
Publikováno v:
Neurotrauma Reports, Vol 4, Iss 1, Pp 404-409 (2023)
Chronic consequences of mild traumatic brain injury (mTBI) are heterogeneous, but may be treatable with targeted medical and rehabilitation interventions. A biological signature for the likelihood of response to therapy (i.e., ?predictive? biomarkers
Externí odkaz:
https://doaj.org/article/2c70d99cb441471bbd5737b42f58a222
Autor:
Shawn R. Eagle, Ava M. Puccio, Denes V. Agoston, Michael Mancinelli, Rachel Nwafo, Peyton McIntyre, Allison Agnone, Savannah Tollefson, Michael Collins, Anthony P. Kontos, Walter Schneider, David O. Okonkwo, Ryan J. Soose
Publikováno v:
Neurotrauma Reports, Vol 4, Iss 1, Pp 251-254 (2023)
Sleep disturbances occur in up to 70% of patients with mild traumatic brain injury (mTBI). Modern mTBI management recommends targeted treatment for the patient's unique clinical manifestations (i.e., obstructive sleep apnea, insomnia). The purpose of
Externí odkaz:
https://doaj.org/article/ef865f250a474758a6f6473b52260b1c
Autor:
Katelyn M. Kozinski, Michael L. Himes, Brian J. Lopresti, Joseph R. Hibbeln, Matthew F. Muldoon, Rajesh Narendran, N. Scott Mason, Savannah Tollefson
Publikováno v:
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. 7:998-1006
Docosahexaenoic acid (DHA) shows anti-inflammatory/proresolution effects in the brain. Higher red blood cell (RBC) DHA in humans is associated with improved cognitive performance and a lower risk for suicide. Here, we hypothesized that binding to the
Publikováno v:
Journal of Neurochemistry. 164:401-443
Early applications of positron emission tomography (PET) in psychiatry sought to identify derangements of cerebral blood flow and metabolism. The need for more specific neurochemical imaging probes was soon evident, and these probes initially targete
Autor:
Savannah Tollefson, Clara Stoughton, Michael L. Himes, Kaylynn E. McKinney, Scott Mason, Roberto Ciccocioppo, Rajesh Narendran
Publikováno v:
Biological Psychiatry.
Autor:
Rajesh Narendran, Michael L. Himes, Rehima Jordan, Roberto Ciccocioppo, Brian J. Lopresti, Katherine Roach, Clara J. Stoughton, Margaret R. Flanigan, N. Scott Mason, Savannah Tollefson
Publikováno v:
Biol Psychiatry
OBJECTIVE: An imbalance between neuropeptides that promote stress and resilience, such as corticotrophin-releasing factor (CRF) and nociceptin, has been postulated to underlie relapse in addiction. The objective of this study was to develop a paradig
Autor:
Emade Jaman, Xiaoran Zhang, Jordan Allen, Raj G. Saraiya, Savannah Tollefson, D. Kojo Hamilton, Nduka M. Amankulor
Publikováno v:
Surgical neurology international. 13
Background: The incidence of survival from metastatic spinal disease (MSD) continues to rise. However, open surgery for MSD is associated with significant perioperative morbidity, while minimally invasive percutaneous pedicle screw fixation (MIPPSF)
Publikováno v:
International Review of Psychiatry. 29:567-579
Addiction is composed of three phases: intoxication, withdrawal, and craving. Negative reinforcement, strengthening a behaviour by removing an aversive stimulus, has been associated with the withdrawal phase. An imbalance of neurotransmitters within
Autor:
Rajesh, Narendran, Savannah, Tollefson, Michael L, Himes, Jennifer, Paris, Brian, Lopresti, Roberto, Ciccocioppo, N Scott, Mason
Publikováno v:
The American journal of psychiatry. 176(6)
Nociceptin/orphanin FQ (N/OFQ) is an antistress neuropeptide transmitter in the brain that counteracts corticotropin-releasing factor (CRF)-mediated stress and anxiety symptoms during drug and alcohol withdrawal. It also inhibits the release of a wid
Autor:
Brian J. Lopresti, Michael L. Himes, Savannah Tollefson, Roberto Ciccocioppo, Rajesh Narendran, Jennifer Paris, N. Scott Mason
Objective:Nociceptin/orphanin FQ (N/OFQ) is an antistress neuropeptide transmitter in the brain that counteracts corticotropin-releasing factor (CRF)-mediated stress and anxiety symptoms during dru...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::456ebcde8593e540e5b00983cc501873
http://hdl.handle.net/11581/447492
http://hdl.handle.net/11581/447492